nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2A6—Ifosfamide—testicular cancer	0.196	0.231	CbGbCtD
Methimazole—CYP2B6—Ifosfamide—testicular cancer	0.127	0.15	CbGbCtD
Methimazole—CYP2C19—Ifosfamide—testicular cancer	0.081	0.0953	CbGbCtD
Methimazole—CYP2C9—Ifosfamide—testicular cancer	0.0673	0.0793	CbGbCtD
Methimazole—CYP2B6—Cisplatin—testicular cancer	0.062	0.073	CbGbCtD
Methimazole—CYP2E1—Etoposide—testicular cancer	0.0617	0.0727	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—testicular cancer	0.0415	0.0489	CbGbCtD
Methimazole—CYP3A4—Ifosfamide—testicular cancer	0.0391	0.0461	CbGbCtD
Methimazole—CYP1A2—Etoposide—testicular cancer	0.0357	0.042	CbGbCtD
Methimazole—CYP2C9—Cisplatin—testicular cancer	0.0327	0.0386	CbGbCtD
Methimazole—CYP2D6—Vinblastine—testicular cancer	0.0327	0.0385	CbGbCtD
Methimazole—CYP3A4—Vinblastine—testicular cancer	0.0208	0.0245	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—testicular cancer	0.0201	0.0236	CbGbCtD
Methimazole—CYP3A4—Etoposide—testicular cancer	0.0187	0.022	CbGbCtD
Methimazole—CYP3A4—Doxorubicin—testicular cancer	0.0128	0.015	CbGbCtD
Methimazole—Drug fever—Chlorambucil—testicular cancer	0.00999	0.0663	CcSEcCtD
Methimazole—Pigmentation disorder—Etoposide—testicular cancer	0.00522	0.0346	CcSEcCtD
Methimazole—Neuritis—Chlorambucil—testicular cancer	0.00447	0.0296	CcSEcCtD
Methimazole—Neuritis—Vinblastine—testicular cancer	0.00409	0.0271	CcSEcCtD
Methimazole—Pigmentation disorder—Epirubicin—testicular cancer	0.00292	0.0194	CcSEcCtD
Methimazole—Lymphadenopathy—Chlorambucil—testicular cancer	0.00284	0.0188	CcSEcCtD
Methimazole—Pigmentation disorder—Doxorubicin—testicular cancer	0.00271	0.018	CcSEcCtD
Methimazole—Ageusia—Cisplatin—testicular cancer	0.00235	0.0156	CcSEcCtD
Methimazole—Aplastic anaemia—Dactinomycin—testicular cancer	0.00226	0.015	CcSEcCtD
Methimazole—Neuropathy peripheral—Chlorambucil—testicular cancer	0.00183	0.0121	CcSEcCtD
Methimazole—Body temperature increased—Carboplatin—testicular cancer	0.00183	0.0121	CcSEcCtD
Methimazole—Jaundice—Chlorambucil—testicular cancer	0.00182	0.0121	CcSEcCtD
Methimazole—Neuropathy peripheral—Vinblastine—testicular cancer	0.00168	0.0111	CcSEcCtD
Methimazole—Agranulocytosis—Vinblastine—testicular cancer	0.00159	0.0106	CcSEcCtD
Methimazole—Alopecia—Chlorambucil—testicular cancer	0.00148	0.00982	CcSEcCtD
Methimazole—Alopecia—Vinblastine—testicular cancer	0.00136	0.00899	CcSEcCtD
Methimazole—Neuritis—Epirubicin—testicular cancer	0.00131	0.00868	CcSEcCtD
Methimazole—Leukopenia—Chlorambucil—testicular cancer	0.0013	0.00865	CcSEcCtD
Methimazole—Agranulocytosis—Dactinomycin—testicular cancer	0.00126	0.00833	CcSEcCtD
Methimazole—Neuritis—Doxorubicin—testicular cancer	0.00121	0.00803	CcSEcCtD
Methimazole—Neuropathy peripheral—Ifosfamide—testicular cancer	0.00121	0.00802	CcSEcCtD
Methimazole—Hepatitis—Dactinomycin—testicular cancer	0.00121	0.00802	CcSEcCtD
Methimazole—Ageusia—Epirubicin—testicular cancer	0.00121	0.008	CcSEcCtD
Methimazole—Vertigo—Vinblastine—testicular cancer	0.0012	0.00796	CcSEcCtD
Methimazole—Leukopenia—Vinblastine—testicular cancer	0.0012	0.00793	CcSEcCtD
Methimazole—Thrombocytopenia—Chlorambucil—testicular cancer	0.00116	0.00773	CcSEcCtD
Methimazole—Agranulocytosis—Ifosfamide—testicular cancer	0.00115	0.00764	CcSEcCtD
Methimazole—Alopecia—Bleomycin—testicular cancer	0.00114	0.0076	CcSEcCtD
Methimazole—Ageusia—Doxorubicin—testicular cancer	0.00112	0.0074	CcSEcCtD
Methimazole—Hepatitis—Ifosfamide—testicular cancer	0.00111	0.00735	CcSEcCtD
Methimazole—Alopecia—Dactinomycin—testicular cancer	0.00107	0.00708	CcSEcCtD
Methimazole—Thrombocytopenia—Vinblastine—testicular cancer	0.00107	0.00708	CcSEcCtD
Methimazole—Dyspepsia—Chlorambucil—testicular cancer	0.00105	0.00695	CcSEcCtD
Methimazole—Neuropathy peripheral—Cisplatin—testicular cancer	0.00104	0.00692	CcSEcCtD
Methimazole—Leukopenia—Bleomycin—testicular cancer	0.00101	0.0067	CcSEcCtD
Methimazole—Aplastic anaemia—Methotrexate—testicular cancer	0.000979	0.0065	CcSEcCtD
Methimazole—Paraesthesia—Vinblastine—testicular cancer	0.000979	0.00649	CcSEcCtD
Methimazole—Alopecia—Ifosfamide—testicular cancer	0.000979	0.00649	CcSEcCtD
Methimazole—Myalgia—Bleomycin—testicular cancer	0.00096	0.00637	CcSEcCtD
Methimazole—Neuropathy peripheral—Etoposide—testicular cancer	0.000955	0.00634	CcSEcCtD
Methimazole—Jaundice—Etoposide—testicular cancer	0.00095	0.0063	CcSEcCtD
Methimazole—Urticaria—Chlorambucil—testicular cancer	0.000945	0.00627	CcSEcCtD
Methimazole—Leukopenia—Dactinomycin—testicular cancer	0.000942	0.00625	CcSEcCtD
Methimazole—Body temperature increased—Chlorambucil—testicular cancer	0.00094	0.00624	CcSEcCtD
Methimazole—Oedema—Bleomycin—testicular cancer	0.000921	0.00611	CcSEcCtD
Methimazole—Aplastic anaemia—Epirubicin—testicular cancer	0.000917	0.00608	CcSEcCtD
Methimazole—Agranulocytosis—Etoposide—testicular cancer	0.000909	0.00603	CcSEcCtD
Methimazole—Thrombocytopenia—Bleomycin—testicular cancer	0.000901	0.00598	CcSEcCtD
Methimazole—Myalgia—Dactinomycin—testicular cancer	0.000896	0.00594	CcSEcCtD
Methimazole—Lymphadenopathy—Methotrexate—testicular cancer	0.000888	0.00589	CcSEcCtD
Methimazole—Vertigo—Ifosfamide—testicular cancer	0.000866	0.00575	CcSEcCtD
Methimazole—Leukopenia—Ifosfamide—testicular cancer	0.000863	0.00572	CcSEcCtD
Methimazole—Oedema—Dactinomycin—testicular cancer	0.000859	0.0057	CcSEcCtD
Methimazole—Aplastic anaemia—Doxorubicin—testicular cancer	0.000848	0.00563	CcSEcCtD
Methimazole—Alopecia—Cisplatin—testicular cancer	0.000844	0.0056	CcSEcCtD
Methimazole—Pruritus—Chlorambucil—testicular cancer	0.000841	0.00558	CcSEcCtD
Methimazole—Thrombocytopenia—Dactinomycin—testicular cancer	0.000841	0.00558	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000839	0.00556	CcSEcCtD
Methimazole—Lymphadenopathy—Epirubicin—testicular cancer	0.000831	0.00551	CcSEcCtD
Methimazole—Paraesthesia—Bleomycin—testicular cancer	0.000827	0.00548	CcSEcCtD
Methimazole—Myalgia—Ifosfamide—testicular cancer	0.000821	0.00544	CcSEcCtD
Methimazole—Arthralgia—Ifosfamide—testicular cancer	0.000821	0.00544	CcSEcCtD
Methimazole—Oedema—Ifosfamide—testicular cancer	0.000787	0.00522	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000782	0.00519	CcSEcCtD
Methimazole—Alopecia—Etoposide—testicular cancer	0.000773	0.00513	CcSEcCtD
Methimazole—Thrombocytopenia—Ifosfamide—testicular cancer	0.00077	0.00511	CcSEcCtD
Methimazole—Lymphadenopathy—Doxorubicin—testicular cancer	0.000769	0.0051	CcSEcCtD
Methimazole—Vomiting—Chlorambucil—testicular cancer	0.000756	0.00502	CcSEcCtD
Methimazole—Leukopenia—Cisplatin—testicular cancer	0.000744	0.00494	CcSEcCtD
Methimazole—Urticaria—Bleomycin—testicular cancer	0.000731	0.00485	CcSEcCtD
Methimazole—Body temperature increased—Bleomycin—testicular cancer	0.000728	0.00483	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000717	0.00476	CcSEcCtD
Methimazole—Myalgia—Cisplatin—testicular cancer	0.000708	0.00469	CcSEcCtD
Methimazole—Nausea—Chlorambucil—testicular cancer	0.000706	0.00469	CcSEcCtD
Methimazole—Paraesthesia—Ifosfamide—testicular cancer	0.000706	0.00469	CcSEcCtD
Methimazole—Somnolence—Ifosfamide—testicular cancer	0.000699	0.00464	CcSEcCtD
Methimazole—Vomiting—Vinblastine—testicular cancer	0.000693	0.0046	CcSEcCtD
Methimazole—Vertigo—Etoposide—testicular cancer	0.000684	0.00454	CcSEcCtD
Methimazole—Headache—Vinblastine—testicular cancer	0.000683	0.00453	CcSEcCtD
Methimazole—Leukopenia—Etoposide—testicular cancer	0.000682	0.00452	CcSEcCtD
Methimazole—Body temperature increased—Dactinomycin—testicular cancer	0.000679	0.0045	CcSEcCtD
Methimazole—Oedema—Cisplatin—testicular cancer	0.000678	0.0045	CcSEcCtD
Methimazole—Thrombocytopenia—Cisplatin—testicular cancer	0.000664	0.00441	CcSEcCtD
Methimazole—Pruritus—Bleomycin—testicular cancer	0.000651	0.00432	CcSEcCtD
Methimazole—Nausea—Vinblastine—testicular cancer	0.000647	0.0043	CcSEcCtD
Methimazole—Urticaria—Ifosfamide—testicular cancer	0.000625	0.00415	CcSEcCtD
Methimazole—Body temperature increased—Ifosfamide—testicular cancer	0.000622	0.00413	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000618	0.0041	CcSEcCtD
Methimazole—Paraesthesia—Cisplatin—testicular cancer	0.000609	0.00404	CcSEcCtD
Methimazole—Thrombocytopenia—Etoposide—testicular cancer	0.000608	0.00404	CcSEcCtD
Methimazole—Vomiting—Bleomycin—testicular cancer	0.000585	0.00388	CcSEcCtD
Methimazole—Drowsiness—Methotrexate—testicular cancer	0.000584	0.00387	CcSEcCtD
Methimazole—Rash—Bleomycin—testicular cancer	0.00058	0.00385	CcSEcCtD
Methimazole—Dermatitis—Bleomycin—testicular cancer	0.00058	0.00385	CcSEcCtD
Methimazole—Paraesthesia—Etoposide—testicular cancer	0.000558	0.0037	CcSEcCtD
Methimazole—Pruritus—Ifosfamide—testicular cancer	0.000557	0.00369	CcSEcCtD
Methimazole—Somnolence—Etoposide—testicular cancer	0.000552	0.00366	CcSEcCtD
Methimazole—Nausea—Bleomycin—testicular cancer	0.000547	0.00363	CcSEcCtD
Methimazole—Drowsiness—Epirubicin—testicular cancer	0.000546	0.00362	CcSEcCtD
Methimazole—Vomiting—Dactinomycin—testicular cancer	0.000546	0.00362	CcSEcCtD
Methimazole—Agranulocytosis—Methotrexate—testicular cancer	0.000545	0.00361	CcSEcCtD
Methimazole—Rash—Dactinomycin—testicular cancer	0.000541	0.00359	CcSEcCtD
Methimazole—Body temperature increased—Cisplatin—testicular cancer	0.000536	0.00356	CcSEcCtD
Methimazole—Neuropathy peripheral—Epirubicin—testicular cancer	0.000535	0.00355	CcSEcCtD
Methimazole—Jaundice—Epirubicin—testicular cancer	0.000532	0.00353	CcSEcCtD
Methimazole—Hepatitis—Methotrexate—testicular cancer	0.000524	0.00348	CcSEcCtD
Methimazole—Nausea—Dactinomycin—testicular cancer	0.00051	0.00338	CcSEcCtD
Methimazole—Agranulocytosis—Epirubicin—testicular cancer	0.00051	0.00338	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—testicular cancer	0.000505	0.00335	CcSEcCtD
Methimazole—Vomiting—Ifosfamide—testicular cancer	0.0005	0.00332	CcSEcCtD
Methimazole—Rash—Ifosfamide—testicular cancer	0.000496	0.00329	CcSEcCtD
Methimazole—Dermatitis—Ifosfamide—testicular cancer	0.000496	0.00329	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000495	0.00329	CcSEcCtD
Methimazole—Urticaria—Etoposide—testicular cancer	0.000494	0.00328	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—testicular cancer	0.000493	0.00327	CcSEcCtD
Methimazole—Body temperature increased—Etoposide—testicular cancer	0.000491	0.00326	CcSEcCtD
Methimazole—Hepatitis—Epirubicin—testicular cancer	0.00049	0.00325	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—testicular cancer	0.000472	0.00313	CcSEcCtD
Methimazole—Nausea—Ifosfamide—testicular cancer	0.000467	0.0031	CcSEcCtD
Methimazole—Alopecia—Methotrexate—testicular cancer	0.000463	0.00307	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—testicular cancer	0.000454	0.00301	CcSEcCtD
Methimazole—Pruritus—Etoposide—testicular cancer	0.00044	0.00292	CcSEcCtD
Methimazole—Alopecia—Epirubicin—testicular cancer	0.000433	0.00287	CcSEcCtD
Methimazole—Vomiting—Cisplatin—testicular cancer	0.000431	0.00286	CcSEcCtD
Methimazole—Rash—Cisplatin—testicular cancer	0.000428	0.00284	CcSEcCtD
Methimazole—Dermatitis—Cisplatin—testicular cancer	0.000427	0.00283	CcSEcCtD
Methimazole—Vertigo—Methotrexate—testicular cancer	0.00041	0.00272	CcSEcCtD
Methimazole—Leukopenia—Methotrexate—testicular cancer	0.000408	0.00271	CcSEcCtD
Methimazole—Nausea—Cisplatin—testicular cancer	0.000403	0.00267	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—testicular cancer	0.000401	0.00266	CcSEcCtD
Methimazole—Vomiting—Etoposide—testicular cancer	0.000395	0.00262	CcSEcCtD
Methimazole—Rash—Etoposide—testicular cancer	0.000392	0.0026	CcSEcCtD
Methimazole—Dermatitis—Etoposide—testicular cancer	0.000391	0.0026	CcSEcCtD
Methimazole—Headache—Etoposide—testicular cancer	0.000389	0.00258	CcSEcCtD
Methimazole—Myalgia—Methotrexate—testicular cancer	0.000388	0.00258	CcSEcCtD
Methimazole—Arthralgia—Methotrexate—testicular cancer	0.000388	0.00258	CcSEcCtD
Methimazole—Vertigo—Epirubicin—testicular cancer	0.000383	0.00254	CcSEcCtD
Methimazole—Leukopenia—Epirubicin—testicular cancer	0.000382	0.00253	CcSEcCtD
Methimazole—Nausea—Etoposide—testicular cancer	0.000369	0.00245	CcSEcCtD
Methimazole—Thrombocytopenia—Methotrexate—testicular cancer	0.000364	0.00242	CcSEcCtD
Methimazole—Myalgia—Epirubicin—testicular cancer	0.000363	0.00241	CcSEcCtD
Methimazole—Arthralgia—Epirubicin—testicular cancer	0.000363	0.00241	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—testicular cancer	0.000355	0.00235	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—testicular cancer	0.000353	0.00235	CcSEcCtD
Methimazole—Oedema—Epirubicin—testicular cancer	0.000348	0.00231	CcSEcCtD
Methimazole—Thrombocytopenia—Epirubicin—testicular cancer	0.000341	0.00226	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000339	0.00225	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—testicular cancer	0.000336	0.00223	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—testicular cancer	0.000336	0.00223	CcSEcCtD
Methimazole—Paraesthesia—Methotrexate—testicular cancer	0.000334	0.00222	CcSEcCtD
Methimazole—Somnolence—Methotrexate—testicular cancer	0.000331	0.0022	CcSEcCtD
Methimazole—Dyspepsia—Methotrexate—testicular cancer	0.000328	0.00217	CcSEcCtD
Methimazole—Oedema—Doxorubicin—testicular cancer	0.000322	0.00214	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000317	0.00211	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—testicular cancer	0.000316	0.00209	CcSEcCtD
Methimazole—Paraesthesia—Epirubicin—testicular cancer	0.000313	0.00208	CcSEcCtD
Methimazole—Somnolence—Epirubicin—testicular cancer	0.00031	0.00205	CcSEcCtD
Methimazole—Dyspepsia—Epirubicin—testicular cancer	0.000307	0.00203	CcSEcCtD
Methimazole—Urticaria—Methotrexate—testicular cancer	0.000296	0.00196	CcSEcCtD
Methimazole—Body temperature increased—Methotrexate—testicular cancer	0.000294	0.00195	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000294	0.00195	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—testicular cancer	0.000289	0.00192	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—testicular cancer	0.000287	0.0019	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—testicular cancer	0.000284	0.00188	CcSEcCtD
Methimazole—Urticaria—Epirubicin—testicular cancer	0.000277	0.00184	CcSEcCtD
Methimazole—Body temperature increased—Epirubicin—testicular cancer	0.000275	0.00183	CcSEcCtD
Methimazole—Pruritus—Methotrexate—testicular cancer	0.000263	0.00175	CcSEcCtD
Methimazole—Urticaria—Doxorubicin—testicular cancer	0.000256	0.0017	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—testicular cancer	0.000255	0.00169	CcSEcCtD
Methimazole—Pruritus—Epirubicin—testicular cancer	0.000246	0.00163	CcSEcCtD
Methimazole—Vomiting—Methotrexate—testicular cancer	0.000237	0.00157	CcSEcCtD
Methimazole—Rash—Methotrexate—testicular cancer	0.000235	0.00156	CcSEcCtD
Methimazole—Dermatitis—Methotrexate—testicular cancer	0.000234	0.00156	CcSEcCtD
Methimazole—Headache—Methotrexate—testicular cancer	0.000233	0.00155	CcSEcCtD
Methimazole—Pruritus—Doxorubicin—testicular cancer	0.000228	0.00151	CcSEcCtD
Methimazole—Vomiting—Epirubicin—testicular cancer	0.000221	0.00147	CcSEcCtD
Methimazole—Nausea—Methotrexate—testicular cancer	0.000221	0.00147	CcSEcCtD
Methimazole—Rash—Epirubicin—testicular cancer	0.00022	0.00146	CcSEcCtD
Methimazole—Dermatitis—Epirubicin—testicular cancer	0.000219	0.00146	CcSEcCtD
Methimazole—Headache—Epirubicin—testicular cancer	0.000218	0.00145	CcSEcCtD
Methimazole—Nausea—Epirubicin—testicular cancer	0.000207	0.00137	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—testicular cancer	0.000205	0.00136	CcSEcCtD
Methimazole—Rash—Doxorubicin—testicular cancer	0.000203	0.00135	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—testicular cancer	0.000203	0.00135	CcSEcCtD
Methimazole—Headache—Doxorubicin—testicular cancer	0.000202	0.00134	CcSEcCtD
Methimazole—Nausea—Doxorubicin—testicular cancer	0.000191	0.00127	CcSEcCtD
